Symbicort Turbuhaler 30/60 Clinical Experience Investigation (SURE)

AstraZeneca

Status: Completed

Conditions: Bronchial Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT01232348

D589IL00001

Details and patient eligibility

About

The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Patient satisfaction

Enrollment: 3,643 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients treated with Symbicort for the first time due to bronchial asthma

Exclusion criteria

Trial design

3,643 participants in 1 patient group

Symbicort

Description:

Those with an exposure